These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33028322)

  • 1. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Bonadia N; Bruno P; Angelini F; Di Stasi C; Contegiacomo A; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Cardiovasc Diabetol; 2020 Sep; 19(1):147. PubMed ID: 32977814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population.
    Rando MM; Biscetti F; Cecchini AL; Nardella E; Nicolazzi MA; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Gasbarrini A; Massetti M; Flex A
    Cardiovasc Diabetol; 2022 Oct; 21(1):214. PubMed ID: 36244983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study.
    Nardella E; Biscetti F; Rando MM; Cecchini AL; Nicolazzi MA; Rossini E; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Massetti M; Gasbarrini A; Flex A
    Cardiovasc Diabetol; 2023 Jun; 22(1):136. PubMed ID: 37308885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease.
    Biscetti F; Nardella E; Bonadia N; Angelini F; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
    Cardiovasc Diabetol; 2019 Jun; 18(1):74. PubMed ID: 31167666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes.
    Biscetti F; Ferraro PM; Hiatt WR; Angelini F; Nardella E; Cecchini AL; Santoliquido A; Pitocco D; Landolfi R; Flex A
    Diabetes Care; 2019 Oct; 42(10):1939-1945. PubMed ID: 31371431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study.
    Szczeklik W; Krzanowski M; Maga P; Partyka Ł; Kościelniak J; Kaczmarczyk P; Maga M; Pieczka P; Suska A; Wachsmann A; Górka J; Biccard B; Devereaux PJ
    Clin Res Cardiol; 2018 Apr; 107(4):319-328. PubMed ID: 29177795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decreased serum omentin-1 level may be an independent risk factor for peripheral arterial disease.
    Onur I; Oz F; Yildiz S; Kuplay H; Yucel C; Sigirci S; Elitok A; Pilten S; Kasali K; Yasar Cizgici A; Erentug V; Dinckal HM
    Int Angiol; 2014 Oct; 33(5):455-60. PubMed ID: 25294287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes.
    Yoo HJ; Hwang SY; Hong HC; Choi HY; Yang SJ; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH
    Cardiovasc Diabetol; 2011 Nov; 10():103. PubMed ID: 22108456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization.
    Kadoglou NPE; Korakas E; Karkos C; Maratou E; Kanonidis I; Plotas P; Papanas N; Moutsatsou P; Ikonomidis I; Lambadiari V
    Cardiovasc Diabetol; 2021 Nov; 20(1):221. PubMed ID: 34758835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with depression are less likely to go home after critical limb revascularization.
    Ramirez JL; Zahner GJ; Arya S; Grenon SM; Gasper WJ; Sosa JA; Conte MS; Iannuzzi JC
    J Vasc Surg; 2021 Jul; 74(1):178-186.e2. PubMed ID: 33383108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term mortality benefit of renin-angiotensin system inhibitors in patients with chronic limb-threatening ischemia undergoing vascular intervention.
    Bodewes TCF; Darling JD; O'Donnell TFX; Deery SE; Shean KE; Mittleman MA; Moll FL; Schermerhorn ML
    J Vasc Surg; 2018 Mar; 67(3):800-808.e1. PubMed ID: 29079009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.
    Liang P; Li C; O'Donnell TFX; Lo RC; Soden PA; Swerdlow NJ; Schermerhorn ML
    J Vasc Surg; 2019 Feb; 69(2):482-489. PubMed ID: 30301689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sortilin/Omentin-1 ratio in peripheral artery disease: A cross-sectional study on 295 unselected elderly patients.
    Giovannini S; Biscetti F; Brau F; Biscotti L; Santoliquido A; Pitocco D; Bernabei R; Flex A
    Mech Ageing Dev; 2022 Jul; 205():111677. PubMed ID: 35500800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization.
    Kim TI; Brahmandam A; Sarac TP; Orion KC
    Vasc Med; 2020 Dec; 25(6):527-533. PubMed ID: 33019909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus.
    Yoo HJ; Hwang SY; Hong HC; Choi HY; Yang SJ; Lee KW; Nam MS; Park YS; Woo JT; Kim YS; Choi KM; Baik SH
    Endocrine; 2013 Dec; 44(3):680-7. PubMed ID: 23532633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    J Vasc Surg; 2019 Jun; 69(6S):126S-136S. PubMed ID: 31159976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in major limb outcomes by indication for lower extremity endovascular revascularization in patients receiving hemodialysis.
    Iwai T; Yamaguchi T; Ueshima D; Tobita K; Mizuno A; Fujimoto Y; Miyazaki R; Shimura T; Goto R; Murata N; Anzai H; Higashitani M
    Heart Vessels; 2023 Apr; 38(4):488-496. PubMed ID: 36322238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.